Skip to main content
. 2021 Apr 27;15(1):56. doi: 10.3892/br.2021.1432

Figure 7.

Figure 7

Effect of oxymatrine on the expression of AKT, PEPCK and G6Pase in HepG2 cells. (A) mRNA expression levels of PEPCK and (B) G6Pase in the treated cells. (C) Protein expression of PEPCK, G6Pase, AKT and pAKT. (D) Ratio of PEPCK, (E) G6Pase and (F) pAKT to β-actin. Differences between groups were compared using a one-way ANOVA. All experiments were repeated 3 times and all data are presented as the mean ± standard deviation. ***P<0.001 vs. control; #P<0.05, ##P<0.01 vs. High Glucose. +oxymatrine (L) cells treated with 0.1 µM oxymatrine; +oxymatrine (H) cells treated with 1 µM oxymatrine; +Metformin, cells treated with 0.1 µM metformin; PEPCK, phosphoenolpyruvate carboxykinase; glucose-6-phosphatase; p, phospho.